Psyence Biomedical (PBM) Loans - Net (2026)
Psyence Biomedical (PBM) posted Loans - Net of $252985.0 for Q1 2026.
Powered by 
Analysis
Psyence Biomedical (PBM) Loans - Net (2026) Analysis & Trends
Psyence Biomedical has reported Loans - Net for 1 years, with the latest figure at $252985.0 in Q1 2026.
- On a quarterly basis, Loans - Net changed N/A year-over-year to $252985.0 in Q1 2026; TTM through Mar 2026 was $252985.0, a N/A change from a year earlier, with the FY2026 full-year figure at $252985.0, changed N/A from the prior year.
- Loans - Net was $252985.0 for Q1 2026 at Psyence Biomedical.
- The five-year high for Loans - Net was $252985.0 in Q1 2026, with the low at $252985.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.17 Bn | 193.18 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.52 Bn | 176.34 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.47 Bn | 123.62 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.73 Bn | 73.74 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.16 Bn | 55.98 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.28 Bn | 48.14 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.06 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.65 Bn | 30.37 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.30 Bn | 29.30 Bn | 1.16 Mn | - |
| 10 | Psyence Biomedical | 2.63 Mn | 2.63 Mn | - | 252,985.00 |